NEW YORK (GenomeWeb) – Merck today announced it would join the Structural Genomics Consortium (SGC) by making a C$7.5 million (US$6 million) contribution to the network.

The investment supports research projects to develop molecular probes to study epigenetic mechanisms of gene regulation. Use of the probes will expand the understanding of biology in multiple disease areas, particularly cancer and inflammatory diseases, the firm said in a statement.

Merck and SGC said that the supported projects "focus on precompetitive research to develop" the chemical probes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

 Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.